StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)

Equities researchers at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued to investors on Sunday. The brokerage set a “hold” rating on the stock.

Separately, Benchmark reaffirmed a “speculative buy” rating and set a $1.25 target price on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Stock Performance

Shares of MLSS opened at $0.95 on Friday. The stock has a 50-day moving average of $0.83 and a two-hundred day moving average of $0.87. The stock has a market cap of $74.00 million, a P/E ratio of -13.57 and a beta of 1.10. Milestone Scientific has a one year low of $0.52 and a one year high of $1.10.

Insider Activity at Milestone Scientific

In other news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the transaction, the director now owns 4,606,882 shares in the company, valued at $4,284,400.26. The trade was a 2.29 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 24.75% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Geode Capital Management LLC boosted its stake in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares during the period. Y Intercept Hong Kong Ltd purchased a new stake in shares of Milestone Scientific in the 3rd quarter valued at approximately $48,000. Finally, World Investment Advisors LLC purchased a new position in shares of Milestone Scientific during the 3rd quarter worth approximately $91,000. 5.79% of the stock is currently owned by hedge funds and other institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.